Are you looking for a stock?
Try one of these
Valeant Pharmaceuticals International Inc. (VRX-T) said it has agreed to buy Russian pharma company Natur Produkt International, JSC for about $180 million, with an additional $5 million in potential future milestones.
The transaction is expected to close by mid-year 2012, Valeant said in a statement.